Delayed Severe Presentation of Chronic Granulomatous Disorder in Adulthood: A Case Report
Abstract
Chronic granulomatous disease (CGD) is the most common inherited phagocytic disorder with an increased susceptibility to recurrent infections and inflammatory manifestations due to a defect in any of the 5 NADPH oxidase subunits. Although CGD may manifest at different ages based on the defects of NADPH oxidase proteins, it is usually diagnosed in childhood with an overall median age of 2.7 to 3 years at the onset.
Infections and inflammatory manifestations are known to be two major clinical presentations of CGD, with the infections occurring much earlier in life than the inflammatory manifestations. Despite the patients’ clinical history and their noticeable manifestations, sometimes the diagnosis is delayed until adulthood, which could be attributed to physicians’ low awareness of the disease. Another reason for such delayed diagnosis could be the fact that some CGD mutations may remain asymptomatic up to a certain age.
The current study is a report of a healthy woman without any history of recurrent infections or inflammation until she was forty. In her early forties, she contracted a mycobacterial infection that was unresponsive to treatment, and was then diagnosed with abnormal reactive oxygen species released by neutrophils, suggesting a case of CGD.
This suggests that primary immunodeficiencies are not solely childhood disorders and should be considered in all refractory or therapy resistant conditions, even in adults.
2. Rekabi M, Shadmehr MB, Mortaz E, Rekabi V, Heydarazad M, Darougar S. Carrier state of chronic granulomatous disease presented at middle age: a case report. Shiraz E-Medical Journal. 2023.
3. Seger R. Chronic granulomatous disease 2018: advances in pathophysiology and clinical management. LymphoSign J. 2019(ja).
4. Köker MY, Camcıoğlu Y, Van Leeuwen K, Kılıç SŞ, Barlan I, Yılmaz M, et al. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J Allergy Clin Immunol. 2013;132(5):1156–1163.e5.
5. Schwenkenbecher P, Neyazi A, Donnerstag F, Ringshausen FC, Jacobs R, Stoll M, et al. Chronic granulomatous disease first diagnosed in adulthood presenting with spinal cord infection. Front Immunol. 2018;9:1258.
6. Marciano BE, Zerbe CS, Falcone EL, Ding L, DeRavin SS, Daub J, et al. X-linked carriers of chronic granulomatous disease: illness, lyonization, and stability. J Allergy Clin Immunol. 2018;141(1):365–71.
7. Barkai T, Somech R, Broides A, Gavrieli R, Wolach B, Marcus N, et al. Late diagnosis of chronic granulomatous disease. Clin Exp Immunol. 2020;201(3):297–305.
8. Dunogué B, Pilmis B, Mahlaoui N, Elie C, Coignard-Biehler H, Amazzough K, et al. Chronic granulomatous disease in patients reaching adulthood: a nationwide study in France. Clin Infect Dis. 2017;64(6):767–75.
9. Marois L, Drouin D, Leduc C, Fernandez I, Manganas H, Gosse G, et al. Chronic granulomatous disease presenting at age 52 with fulminant mulch pneumonitis. J Allergy Clin Immunol Global. 2022;1(4):322–24.
10. Rider NL, Jameson MB, Creech CB. Chronic granulomatous disease: epidemiology, pathophysiology, and genetic basis of disease. J Pediatric Infect Dis Soc. 2018;7(suppl_1):S2–5.
11. Darougar S, Rashid Farokhi F, Tajik S, Baghaie N, Amirmoini M, Bashardoust B, et al. Amyloidosis as a renal complication of chronic granulomatous disease. Iran J Kidney Dis. 2016;10(4):228–32.
12. Mondal S, Vignesh P, Loganathan SK, Arora K, Das J, Rawat A, et al. Case report: chronic granulomatous disease presenting with early-onset inflammatory bowel disease and normal oxidative burst testing. Front Pediatr. 2023;10:964025.
13. Robles-Marhuenda A, Álvarez-Troncoso J, Rodríguez-Pena R, Busca-Arenzana C, López-Granados E, Arnalich-Fernandez F. Chronic granulomatous disease: single-center Spanish experience. Clin Immunol. 2020;211:108323.
| Files | ||
| Issue | Articles in Press | |
| Section | Case Report(s) | |
| Keywords | ||
| Chronic granulomatous disease Delayed diagnosis NADPH oxidases Reactive oxygen species | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |

